Therapeutic Strategy in Case of Hemangiomas in Children

Abstract

Hemangiomas are the most common tumors in infancy constituting 1 – 2.6 % of incidence. Their incidence in preterm newborns with low birth weight (less than 1000 g) can reach 30 %. Increase in the incidence is observed during the first year of life.

Regressing hemangiomas undergo careful observation. Hemangiomas with a high risk of complications (destructive growth, cosmetic defects, ulceration, amblyopia, compression of vital structures) require treatment.

The variety of clinical and morphological features, localization and prevalence of vascular lesions require continual search for effective methods of treatment to determine the optimal terms and methods of therapy.

The objective of the research was to improvement the results of hemangiomas treatment in children.

Materials and methods. The results of treatment of 146 children with voluminous, rapidly growing, and non-regressing hemangiomas, as well as children with poor results of treatment after incorrect therapy were analyzed.

Methods of the research included clinical, morphological, radiation, statistical ones.

Results and discussion. Effectual treatment regimen of rapidly growing and non-regressing hemangiomas with cosmetically important locations, including surgical treatment with the use of high-frequency coagulator EC-300MІ and systemic therapy with propranolol was developed and suggested.

Conclusions. The proposed treatment regimen reduces the volume and intensity of hemangiomas growth. In the majority of cases it allows complete removal of the tumor with a good cosmetic result.